Furosemide Injection
FDA Label NDC 73542-101
Structured Product Label
The following Structured Product Label (SPL) was submitted to the FDA by Maiva Pharma Private Limited for the product Furosemide (NDC 73542-101). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding warnings, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Label Section Quick Index
Package Label.Principal Display Panel
NDC 73542-101-01
Furosemide Injection, USP
20 mg/2 mL
(10 mglmL)
FOR IV OR IM USE
Rx only
2 mL Single-Dose vial
NDC 73542-101-25
Furosemide Injection, USP
20 mg/2 mL
(10 mglmL)
FOR IV OR IM USE
Rx only
25 Single-Dose vial
NDC 73542-102-02
Furosemide Injection, USP
40 mg/4 mL
(10 mglmL)
FOR IV OR IM USE
Rx only
4 mL Single-Dose vial
NDC 73542-102-25
Furosemide Injection, USP
40 mg/4 mL
(10 mglmL)
FOR IV OR IM USE
Rx only
25 Single-Dose via
NDC 73542-103-03
Furosemide Injection, USP
100 mg/10 mL
(10 mglmL)
FOR IV OR IM USE
Rx only
10 mL Single-Dose vial
NDC 73542-103-25
Furosemide Injection, USP
100 mg/10 mL
(10 mglmL)
FOR IV OR IM USE
Rx only
25 Single-Dose vial
* Please review the disclaimer below.